tiprankstipranks
Trending News
More News >
Genscript Biotech (GNNSF)
OTHER OTC:GNNSF
US Market

Genscript Biotech (GNNSF) Stock Forecast & Price Target

Compare
18 Followers
See the Price Targets and Ratings of:

GNNSF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Genscript
Biotech
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GNNSF Stock 12 Month Forecast

There Are No Analyst Ratings for GNNSF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GNNSF Financial Forecast

GNNSF Earnings Forecast

Next quarter’s earnings estimate for GNNSF is -$0.03 with a range of -$0.03 to -$0.03. The previous quarter’s EPS was -$0.02. GNNSF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year GNNSF has Performed in-line its overall industry.
Next quarter’s earnings estimate for GNNSF is -$0.03 with a range of -$0.03 to -$0.03. The previous quarter’s EPS was -$0.02. GNNSF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year GNNSF has Performed in-line its overall industry.

GNNSF Sales Forecast

Next quarter’s sales forecast for GNNSF is $441.15M with a range of $441.15M to $441.15M. The previous quarter’s sales results were $517.53M. GNNSF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year GNNSF has Performed in-line its overall industry.
Next quarter’s sales forecast for GNNSF is $441.15M with a range of $441.15M to $441.15M. The previous quarter’s sales results were $517.53M. GNNSF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year GNNSF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guotai Haitong Analyst forecast on GNNSF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$3.15$3.35
Buy
82.25%
Upside
Reiterated
11/21/25
Guotai Haitong Sticks to Its Buy Rating for Genscript Biotech (GNNSF)
Huatai Securities Analyst forecast on GNNSF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$2.74$2.76
Buy
49.85%
Upside
Reiterated
11/14/25
Huatai Securities Reaffirms Their Buy Rating on Genscript Biotech (GNNSF)
Morgan Stanley Analyst forecast on GNNSF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$2.8
Buy
52.28%
Upside
Reiterated
10/16/25
Citic Securities Analyst forecast on GNNSF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$2.94
Buy
59.93%
Upside
Reiterated
08/22/25
J.P. Morgan Analyst forecast on GNNSF
J.P. Morgan
J.P. Morgan
$2.05$3.07
Buy
66.88%
Upside
Reiterated
08/21/25
J.P. Morgan Reaffirms Their Buy Rating on Genscript Biotech (GNNSF)
CICC Analyst forecast on GNNSF
Unknown Analyst
CICC
Not Ranked
CICC
$2.75
Buy
49.50%
Upside
Reiterated
08/18/25
Daiwa Analyst forecast on GNNSF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$3.33
Buy
80.79%
Upside
Reiterated
08/18/25
BOCOM International Holdings Company Analyst forecast on GNNSF
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
$3.68
Buy
99.91%
Upside
Reiterated
08/18/25
Bank of China Analyst forecast on GNNSF
Unknown Analyst
Bank of China
Not Ranked
Bank of China
$2.69
Buy
46.02%
Upside
Reiterated
03/13/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guotai Haitong Analyst forecast on GNNSF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$3.15$3.35
Buy
82.25%
Upside
Reiterated
11/21/25
Guotai Haitong Sticks to Its Buy Rating for Genscript Biotech (GNNSF)
Huatai Securities Analyst forecast on GNNSF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$2.74$2.76
Buy
49.85%
Upside
Reiterated
11/14/25
Huatai Securities Reaffirms Their Buy Rating on Genscript Biotech (GNNSF)
Morgan Stanley Analyst forecast on GNNSF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$2.8
Buy
52.28%
Upside
Reiterated
10/16/25
Citic Securities Analyst forecast on GNNSF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$2.94
Buy
59.93%
Upside
Reiterated
08/22/25
J.P. Morgan Analyst forecast on GNNSF
J.P. Morgan
J.P. Morgan
$2.05$3.07
Buy
66.88%
Upside
Reiterated
08/21/25
J.P. Morgan Reaffirms Their Buy Rating on Genscript Biotech (GNNSF)
CICC Analyst forecast on GNNSF
Unknown Analyst
CICC
Not Ranked
CICC
$2.75
Buy
49.50%
Upside
Reiterated
08/18/25
Daiwa Analyst forecast on GNNSF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$3.33
Buy
80.79%
Upside
Reiterated
08/18/25
BOCOM International Holdings Company Analyst forecast on GNNSF
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
$3.68
Buy
99.91%
Upside
Reiterated
08/18/25
Bank of China Analyst forecast on GNNSF
Unknown Analyst
Bank of China
Not Ranked
Bank of China
$2.69
Buy
46.02%
Upside
Reiterated
03/13/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Genscript Biotech

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+25.90%
downgraded a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +25.90% per trade.
1 Year
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+25.90%
downgraded a sell rating 2 months ago
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.90% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+25.90%
downgraded a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GNNSF Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
8
8
8
3
3
Buy
0
0
0
0
0
Hold
6
10
25
24
24
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
14
18
33
27
28
In the current month, GNNSF has received 3 Buy Ratings, 24 Hold Ratings, and 1 Sell Ratings. GNNSF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

GNNSF Stock Forecast FAQ

What is GNNSF’s average 12-month price target, according to analysts?
Currently, no data Available
What is GNNSF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GNNSF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is GNNSF a Buy, Sell or Hold?
      Currently, no data Available
      What is Genscript Biotech’s price target?
      Currently, no data Available
      What do analysts say about Genscript Biotech?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of GNNSF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.